Friends study points to ctDNA’s potential to serve as an intermediate endpoint in NSCLC

ctMoniTR project aims to improve efficiency in development of intermediate endpoints

By Jacquelyn Cobb

New research led by Friends of Cancer Research demonstrates that decreases in circulating tumor DNA after initiation of treatment are associated with improved overall survival in patients with advanced non-small cell lung cancer treated with immunotherapy or chemotherapy.